nivolumab (Opdivo)
Drug timelines are a Plus or Pro feature.
41 regulatory and trial events tracked for nivolumab (Opdivo), covering 2015-12-11 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC [Phase 2]